-
US open: Major indices trade higher after Fed rate cut, Nasdaq leads early gains
19 Sep 2025 02:36 GMT
… 6,629.13 and the Nasdaq Composite came out of the … ) $24.90 -0.74%
Amgen Inc. (AMGN) $274.71 -0.65%
Nike … . (URI) $931.01 -2.88%
Nasdaq 100 - Risers
Baidu Inc … . (MCHP) $65.78 2.89%
Nasdaq 100 - Fallers
Broadcom Inc …
-
US open: Stocks lower as shutdown risk offsets Fed-driven rally
22 Sep 2025 19:19 GMT
… 6,649.39 and the Nasdaq Composite came out of the … .com
Dow Jones - Risers
Amgen Inc. (AMGN) $285.41 3.47% … (COTY) $4.11 -3.75%
Nasdaq 100 - Risers
Western Digital … . (ALGN) $131.39 0.00%
Nasdaq 100 - Fallers
Trip.com …
-
European Medicines Agency Recommends Marketing Authorization of AVT03, Alvotech’s Proposed Biosimilar to Prolia® and Xgeva®
22 Sep 2025 10:15 GMT
… , 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company … Xgeva® are registered trademarks of Amgen Inc. Kefdensis® and Zvogra® are …
-
US close: Major indices extend record-setting rally
19 Sep 2025 23:40 GMT
… bolster economic growth.
While the Nasdaq continued to benefit from renewed … .com
Dow Jones - Risers
Amgen Inc. (AMGN) $285.41 3.47% … ) $41.17 3.67%
Amgen Inc. (AMGN) $285.41 3.47%
Synopsys … .11 -3.75%
Nasdaq 100 - Risers
Amgen Inc. (AMGN) $285.41 3 …
-
US open: Major indices build on Thursday's record close
19 Sep 2025 23:41 GMT
… bolster economic growth.
While the Nasdaq continued to benefit from renewed … are rolled or closed, with Nasdaq-linked contracts in particular drawing … ) $241.88 1.68%
Amgen Inc. (AMGN) $278.57 0.99%
… (CHKP) $197.81 0.80%
Nasdaq 100 - Fallers
Micron Technology …
-
This 12% Dividend Is on Sale as a $30 Bn ’Hidden’ Move Sparks Buying Opportunity
18 Sep 2025 09:58 GMT
… is in the large-cap Amgen (NASDAQ:AMGN), while its top-10 holdings … -known firms like Vertex Pharmaceuticals (NASDAQ:VRTX) and Eli Lilly (NYSE …
-
Alvotech Announces Marketing Approval in Japan of Three New Biosimilars
19 Sep 2025 11:45 GMT
… , 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company … ® is a registered trademark of Amgen, Stelara® and Simponi® are a …
-
ArriVent Appoints Brent S. Rice as Chief Commercial Officer
22 Sep 2025 20:05 GMT
… BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP), a clinical-stage company … . He spent 18 years at Amgen in roles of increasing responsibility …
-
London pre-open: Stocks to edge down amid dearth of corporate news
22 Sep 2025 10:41 GMT
… S&P 500 and Nasdaq both advanced to fresh record … the ground, but AstraZeneca and Amgen said their Tezspire drug has …
-
AstraZeneca's Tezspire recommended for US approval, Elixirr reports record interim results
22 Sep 2025 10:42 GMT
STOCKS TO WATCH
AstraZeneca and Amgen said on Monday that their … 6,664.36, and the Nasdaq Composite saw out the session …